On ECHEMI
Home > Drugs > Guangdong Bozhou Pharmaceutical Co., Ltd.

Guangdong Bozhou Pharmaceutical Co., Ltd.

  • Founded in:

    2000-12-07
  • Country:

    China China
  • Address:

    Green Industrial Park, Jiedong Economic Development Zone, Jieyang City
  • Tax NO.:

    9144520372599310X7
  • Registered Funds:

    20 million yuan
  • Email:

Related Drugs
Cefuroxime Sodium for Injection
The main ingredient of this product is cefuroxime sodium and its chemical name is: (6R,7S)-7-[(S)-2-[(2-amino-2-carboxyethyl)thio]acetylamino]-7alpha;-methoxy-3-[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid sodium salt heptahydrate
Name Description Content CAS NO. Registered Holders
CEFMINOX SODIUM

It has a broad spectrum of antibacterial activity against Gram-positive and Gram-negative bacteria, especially against Escherichia coli, Klebsiella, Haemophilus influenzae, Proteus and Bacteroides fragilis. Its mechanism of action is that it shows a strong affinity for penicillin-binding protein, which is the usual point of action of beta-lactam antibiotics, inhibits cell wall synthesis, binds to peptidoglycan, inhibits the binding of peptidoglycan to lipoprotein to promote bacteriolysis, and shows a strong bactericidal effect in a short time. This product shows antibacterial effect on bacteria during the proliferation period and the early stage of the stable period, and has a bactericidal effect at concentrations lower than the MIC, and lyses bacteria in a short time. The antibacterial effect in vivo is stronger than the prediction of MIC.

More

It has a broad spectrum of antibacterial activity against Gram-positive and Gram-negative bacteria, especially against Escherichia coli, Klebsiella, Haemophilus influenzae, Proteus and Bacteroides fragilis. Its mechanism of action is that it shows a strong affinity for penicillin-binding protein, which is the usual point of action of beta-lactam antibiotics, inhibits cell wall synthesis, binds to peptidoglycan, inhibits the binding of peptidoglycan to lipoprotein to promote bacteriolysis, and shows a strong bactericidal effect in a short time. This product shows antibacterial effect on bacteria during the proliferation period and the early stage of the stable period, and has a bactericidal effect at concentrations lower than the MIC, and lyses bacteria in a short time. The antibacterial effect in vivo is stronger than the prediction of MIC.

92636-39-0 29
Cefotezol Sodium for Injection
The main ingredient of this product is ceftriaxone sodium, and its chemical name is (6R,7R)-3-〔[(1,3,4-thiazol-2-yl)thio]methyl〕-7-[(1H-4-oxazol-1-yl)acetylamino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid sodium salt.
Name Description Content CAS NO. Registered Holders
Ceftezole sodium

It exerts antibacterial activity by inhibiting the synthesis of bacterial cell walls and has antibacterial activity against aerobic Gram-positive bacteria (such as Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes) and aerobic Gram-negative bacteria (such as Escherichia coli, Klebsiella pneumoniae, Proteus)

More

It exerts antibacterial activity by inhibiting the synthesis of bacterial cell walls and has antibacterial activity against aerobic Gram-positive bacteria (such as Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes) and aerobic Gram-negative bacteria (such as Escherichia coli, Klebsiella pneumoniae, Proteus)

41136-22-5 25
Cefotezol Sodium for Injection
The main ingredient of this product is ceftriaxone sodium, and its chemical name is (6R,7R)-3-〔[(1,3,4-thiazol-2-yl)thio]methyl〕-7-[(1H-4-oxazol-1-yl)acetylamino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid sodium salt.
Name Description Content CAS NO. Registered Holders
Ceftezole sodium

It exerts antibacterial activity by inhibiting the synthesis of bacterial cell walls and has antibacterial activity against aerobic Gram-positive bacteria (such as Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes) and aerobic Gram-negative bacteria (such as Escherichia coli, Klebsiella pneumoniae, Proteus)

More

It exerts antibacterial activity by inhibiting the synthesis of bacterial cell walls and has antibacterial activity against aerobic Gram-positive bacteria (such as Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes) and aerobic Gram-negative bacteria (such as Escherichia coli, Klebsiella pneumoniae, Proteus)

41136-22-5 25
Cefotezol Sodium for Injection
The main ingredient of this product is ceftriaxone sodium, and its chemical name is (6R,7R)-3-〔[(1,3,4-thiazol-2-yl)thio]methyl〕-7-[(1H-4-oxazol-1-yl)acetylamino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid sodium salt.
Name Description Content CAS NO. Registered Holders
Ceftezole sodium

It exerts its antibacterial activity by inhibiting the synthesis of bacterial cell walls, and has antibacterial activity against aerobic Gram-positive bacteria (such as Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes) and aerobic Gram-negative bacteria (such as Escherichia coli, Klebsiella pneumoniae, Proteus).

More

It exerts its antibacterial activity by inhibiting the synthesis of bacterial cell walls, and has antibacterial activity against aerobic Gram-positive bacteria (such as Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes) and aerobic Gram-negative bacteria (such as Escherichia coli, Klebsiella pneumoniae, Proteus).

41136-22-5 25
Cefotezol Sodium for Injection
The main ingredient of this product is ceftriaxone sodium, and its chemical name is (6R,7R)-3-〔[(1,3,4-thiazol-2-yl)thio]methyl〕-7-[(1H-4-oxazol-1-yl)acetylamino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid sodium salt.
Name Description Content CAS NO. Registered Holders
Ceftezole sodium

It exerts antibacterial activity by inhibiting the synthesis of bacterial cell walls and has antibacterial activity against aerobic Gram-positive bacteria (such as Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes) and aerobic Gram-negative bacteria (such as Escherichia coli, Klebsiella pneumoniae, Proteus)

More

It exerts antibacterial activity by inhibiting the synthesis of bacterial cell walls and has antibacterial activity against aerobic Gram-positive bacteria (such as Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes) and aerobic Gram-negative bacteria (such as Escherichia coli, Klebsiella pneumoniae, Proteus)

41136-22-5 25
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.